EFCAB9 | EF-hand calcium binding domain 9 | | | | | | Tissue enriched |
EGR1 | Early growth response 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
ELOVL7 | ELOVL fatty acid elongase 7 | Enzymes Predicted membrane proteins
| | | | | Mixed |
ERAP1 | Endoplasmic reticulum aminopeptidase 1 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ERAP2 | Endoplasmic reticulum aminopeptidase 2 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ERGIC1 | Endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
F12 | Coagulation factor XII (Hageman factor) | Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
FABP6 | Fatty acid binding protein 6, ileal | Predicted secreted proteins
| | | | | Tissue enriched |
FAM169A | Family with sequence similarity 169, member A | | | | | | Tissue enhanced |
FAM71B | Family with sequence similarity 71, member B | | | | | | Tissue enriched |
FAT2 | FAT atypical cadherin 2 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
FBN2 | Fibrillin 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FCHO2 | FCH domain only 2 | | | | | | Expressed in all |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets RAS pathway related proteins
| | | | | Group enriched |
FYB | FYN binding protein | | | | | | Tissue enhanced |
G3BP1 | GTPase activating protein (SH3 domain) binding protein 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
GABRA1 | Gamma-aminobutyric acid (GABA) A receptor, alpha 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
GM2A | GM2 ganglioside activator | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
GPBP1 | GC-rich promoter binding protein 1 | | | | | | Expressed in all |
GRAMD3 | GRAM domain containing 3 | Predicted membrane proteins
| | | | | Expressed in all |
GRIA1 | Glutamate receptor, ionotropic, AMPA 1 | FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
GRK6 | G protein-coupled receptor kinase 6 | Enzymes
| | | | | Expressed in all |
GRPEL2 | GrpE-like 2, mitochondrial (E. coli) | Mitochondrial proteins
| | | | | Expressed in all |
HAPLN1 | Hyaluronan and proteoglycan link protein 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
HARS | Histidyl-tRNA synthetase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
HAVCR2 | Hepatitis A virus cellular receptor 2 | Predicted membrane proteins
| | | | | Mixed |
HDAC3 | Histone deacetylase 3 | Enzymes FDA approved drug targets
| | | | | Expressed in all |
HEXB | Hexosaminidase B (beta polypeptide) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
HINT1 | Histidine triad nucleotide binding protein 1 | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Expressed in all |
HK3 | Hexokinase 3 (white cell) | Enzymes Plasma proteins
| | | | | Tissue enhanced |
HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) | Enzymes Plasma proteins
| | | | | Expressed in all |
HMMR | Hyaluronan-mediated motility receptor (RHAMM) | CD markers FDA approved drug targets
| | | | | Mixed |
HNRNPAB | Heterogeneous nuclear ribonucleoprotein A/B | Plasma proteins
| | | | | Expressed in all |
HNRNPH1 | Heterogeneous nuclear ribonucleoprotein H1 (H) | Plasma proteins
| | | | | Expressed in all |
HOMER1 | Homer homolog 1 (Drosophila) | | | | | | Tissue enhanced |
HSD17B4 | Hydroxysteroid (17-beta) dehydrogenase 4 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
HSPA9 | Heat shock 70kDa protein 9 (mortalin) | Mitochondrial proteins Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
IK | IK cytokine, down-regulator of HLA II | | | | | | Expressed in all |
IRF1 | Interferon regulatory factor 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ITGA2 | Integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
KDM3B | Lysine (K)-specific demethylase 3B | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
LARS | Leucyl-tRNA synthetase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
LCP2 | Lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | | | | | | Expressed in all |
LMNB1 | Lamin B1 | Disease related genes Plasma proteins
| | | | | Mixed |
LPCAT1 | Lysophosphatidylcholine acyltransferase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
MAN2A1 | Mannosidase, alpha, class 2A, member 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
MAP1B | Microtubule-associated protein 1B | Plasma proteins
| | | | | Tissue enhanced |
MAP3K1 | Mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
MARCH6 | Membrane-associated ring finger (C3HC4) 6, E3 ubiquitin protein ligase | Predicted membrane proteins
| | | | | Expressed in all |